Enabling Discovery with AI: Using Structural Predictions to Influence NextGeneration Kinase Inhibitors
Time: 9:00 am
day: Conference Day One
Details:
- Reimagining the industry’s approach to structure-guided design to reveal how compounds can acquire on-target selectivity
- Harnessing AI to detect conformational changes that can shed light on kinase transition states in the context of drug binding
- Diving into key structural features of the active kinase domain to discover potential sites of intervention
